Trials
Search / Trial NCT05646420

Thyroid Hormones in ADPKD

Launched by MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH · Dec 5, 2022

Trial Information

Current as of January 13, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Male and female ≥18 years old;
  • 2. Diagnosis of ADPKD based on renal ultrasonography or genetic test;
  • 3. Written informed consent
  • Exclusion Criteria:
  • 1. Diagnosis of Hashimoto's disease, hyperthyroidism or pituitary disease or any other condition undergoing levothyroxine replacement
  • 2. Patient with hypothyroidism treated with drug therapy
  • 3. Active treatment with Tolvaptan and/or Octreotide-LAR;
  • 4. Regular treatment with amiodarone, lithium, interferon or immunosuppressive drugs including steroids;
  • 5. Active malignancy or acute or chronic inflammatory disease, HIV;
  • 6. Dialysis or kidney transplantation;
  • 7. Diabetes mellitus;
  • 8. Hypocaloric diet or current dietary approaches to obtain weight loss.
  • 9. Legal incapacity or any evidence that the patient will not be able to understand the study aims and procedures.

About Mario Negri Institute For Pharmacological Research

The Mario Negri Institute for Pharmacological Research is a leading Italian biomedical research organization dedicated to advancing pharmacological science and improving public health. Established in 1963, the Institute focuses on innovative research methodologies, drug development, and clinical trials aimed at understanding and treating various diseases. With a multidisciplinary team of scientists and clinicians, the Institute collaborates with national and international partners to translate research findings into clinical applications, contributing significantly to the fields of pharmacology, epidemiology, and biostatistics. Committed to excellence in research and ethical standards, the Mario Negri Institute plays a vital role in shaping the future of medical science and enhancing therapeutic strategies.

Locations

Ranica, Bg, Italy

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials